Skip to content
The Detroit

FDA adds vision loss warning to Ozempic, Wegovy and other GLP-1 drugs

FDA adds vision loss warning to Ozempic, Wegovy and other GLP-1 drugs
Photo: WXYZ Channel 7 (ABC Detroit) - News · view original

Popular weight loss drugs, including Ozempic and Wegovy, will carry a new warning about a possible rare side effect that can sometimes lead to permanent vision loss, U.S. health regulators announced Monday. The Food and Drug Administration said the risk will be added to the labeling of all GLP-1...

Sources and story details